Aier Eye Hospital Group Co.,Ltd. (300015.SZ) Reports First Half Results with Net Profit of 2.051 Billion Yuan, Up 0.05%

Stock News08-26

Aier Eye Hospital Group Co.,Ltd. (300015.SZ) released its 2025 interim report, showing operating revenue of 11.507 billion yuan, representing a year-on-year increase of 9.12%. Net profit attributable to shareholders reached 2.051 billion yuan, up 0.05% compared to the same period last year. Net profit attributable to shareholders excluding non-recurring items was 2.04 billion yuan, marking a significant increase of 14.30% year-on-year. Basic earnings per share stood at 0.2219 yuan. During the reporting period, the company achieved 9.2483 million outpatient visits, an increase of 16.47% year-on-year, and performed 879,000 surgical procedures, up 7.63% from the previous year. The revenue growth was driven by several factors including gradually strengthening public awareness of eye health, increasing pursuit of better medical outcomes, continuous iteration and upgrading of the company's ophthalmic medical technologies, enhanced service capabilities, and ongoing expansion of operational scale and brand influence.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1126176980?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-08-26 23:32","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1126176980","market":"sg","top_or_hot":-1,"title":"Aier Eye Hospital Group Co.,Ltd. (300015.SZ) Reports First Half Results with Net Profit of 2.051 Billion Yuan, Up 0.05%","media":"Stock News","content":"<p>Aier Eye Hospital Group Co.,Ltd. (300015.SZ) released its 2025 interim report, showing operating revenue of 11.507 billion yuan, representing a year-on-year increase of 9.12%. Net profit attributable to shareholders reached 2.051 billion yuan, up 0.05% compared to the same period last year. Net profit attributable to shareholders excluding non-recurring items was 2.04 billion yuan, marking a significant increase of 14.30% year-on-year. Basic earnings per share stood at 0.2219 yuan. During the reporting period, the company achieved 9.2483 million outpatient visits, an increase of 16.47% year-on-year, and performed 879,000 surgical procedures, up 7.63% from the previous year. The revenue growth was driven by several factors including gradually strengthening public awareness of eye health, increasing pursuit of better medical outcomes, continuous iteration and upgrading of the company's ophthalmic medical technologies, enhanced service capabilities, and ongoing expansion of operational scale and brand influence.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Aier Eye Hospital Group Co.,Ltd. (300015.SZ) Reports First Half Results with Net Profit of 2.051 Billion Yuan, Up 0.05%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAier Eye Hospital Group Co.,Ltd. (300015.SZ) Reports First Half Results with Net Profit of 2.051 Billion Yuan, Up 0.05%\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036600163\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock News </p>\n<p class=\"h-time\">2025-08-26 23:32</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Aier Eye Hospital Group Co.,Ltd. (300015.SZ) released its 2025 interim report, showing operating revenue of 11.507 billion yuan, representing a year-on-year increase of 9.12%. Net profit attributable to shareholders reached 2.051 billion yuan, up 0.05% compared to the same period last year. Net profit attributable to shareholders excluding non-recurring items was 2.04 billion yuan, marking a significant increase of 14.30% year-on-year. Basic earnings per share stood at 0.2219 yuan. During the reporting period, the company achieved 9.2483 million outpatient visits, an increase of 16.47% year-on-year, and performed 879,000 surgical procedures, up 7.63% from the previous year. The revenue growth was driven by several factors including gradually strengthening public awareness of eye health, increasing pursuit of better medical outcomes, continuous iteration and upgrading of the company's ophthalmic medical technologies, enhanced service capabilities, and ongoing expansion of operational scale and brand influence.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LU1146622755.USD","symbol_name":"安本中国A股股票基金A Acc","start_time":0,"source_url":"","article_id":"1126176980","we_media_id":"1036600163","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1126176980","pubTimestamp":1756222340,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Stock News","introduction":"Global Stock News First-Time Broadcast","home_visible":1,"id":"1036600163","head_image":"https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a"},"summary":"Aier Eye Hospital Group Co.,Ltd. (300015.SZ) released its 2025 interim report, showing operating revenue of 11.507 billion yuan, representing a year-on-year increase of 9.12%. Net profit attributable...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"300015":"爱尔眼科","LU1146622755.USD":"安本中国A股股票基金A Acc","BK0200":"360概念","LU1242518857.USD":"FULLERTON LUX FUNDS - ASIA ABSOLUTE ALPHA \"I\" (USD) ACC","BK0028":"国家队","LU1242518931.SGD":"Fullerton Lux Funds - Asia Absolute Alpha A Acc SGD","LU1820825898.SGD":"Aberdeen Standard SICAV I - China A Share Equity A Acc SGD-H","BK0113":"养老产业","LU0979878070.USD":"FULLERTON LUX FUNDS - ASIA ABSOLUTE ALPHA \"A\" (USD) ACC","BK0236":"卫生","BK0114":"健康中国","BK0188":"融资融券","BK0077":"质押式回购","BK0096":"民营医院","BK0012":"证金概念","BK0196":"行业龙头"},"translate_title":"爱尔眼科医院集团有限公司。（300015.SZ）公布上半年业绩净利润20.51亿元增长0.05%","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"300015":1},"content_text":"Aier Eye Hospital Group Co.,Ltd. (300015.SZ) released its 2025 interim report, showing operating revenue of 11.507 billion yuan, representing a year-on-year increase of 9.12%. Net profit attributable to shareholders reached 2.051 billion yuan, up 0.05% compared to the same period last year. Net profit attributable to shareholders excluding non-recurring items was 2.04 billion yuan, marking a significant increase of 14.30% year-on-year. Basic earnings per share stood at 0.2219 yuan. During the reporting period, the company achieved 9.2483 million outpatient visits, an increase of 16.47% year-on-year, and performed 879,000 surgical procedures, up 7.63% from the previous year. The revenue growth was driven by several factors including gradually strengthening public awareness of eye health, increasing pursuit of better medical outcomes, continuous iteration and upgrading of the company's ophthalmic medical technologies, enhanced service capabilities, and ongoing expansion of operational scale and brand influence.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"dataReport","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1126176980","isCrawlerRequest":true}